Fundraising Fox
Clinical ink
Winston-Salem, US · Founded 2013 · Delaware corporation · 3 known investors
Find your way into Clinical ink
Sign up to see every warm intro you have to Clinical ink
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Clinical ink team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Clinicalink offers a digital tool designed to improve drug adherence and measure the functional quality of weight loss. The product operates in the digital health space with clinical expertise spanning cardiology, rare disease, and oncology.
Founders & leadership
Clinical ink was founded in 2013 by Douglas E. Pierce, Jr..
DE
Douglas E. Pierce, Jr.Founder
JS
Joe SchmidtExecutive
ES
Edward S. SeguineExecutive
Board
AG
MK
BG
Brad GeesamanBoard director
RK
Robert KniejskiBoard director
TF
MJ
Morana Jovan-EmbiricosBoard director
PR
Philip RS Waugh, Jr.Board director
Investors · 3
FCA Venture Partnerslisted by FCA Venture PartnersNashville · $500K – $10M
How we know: FCA Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
McKesson Ventureslisted by McKesson VenturesSan Francisco
How we know: McKesson Ventures's portfolio page · Not right? Tell us
MPM BioImpactreportedBoston · $1M – $15Mvia Todd Foley · board
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$16.9M disclosed across 3 rounds · 2015–2018
▶$5.3MraisedMay 2018 · 5 investors · OtherRule 506(b)
▶$5.3MraisedMay 2018 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Matthew KingDirector
- Edward S. Seguine, Jr.Executive Officer, Director
- Richard MalcolmDirector
- Roger LaVern DavenportDirector
- Michael SorensenDirector
- Amount sold
- $5.3M
- Minimum investment
- $2.7K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.7MraisedDec 2017 · 9 investors · OtherRule 506(b)
▶$1.7MraisedDec 2017 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tony RosenbergDirector
- Phil WaughDirector
- Todd FoleyDirector
- Richard MalcolmDirector
- Scott MiltenbergerExecutive Officer
- Edward S. Seguine, Jr.Executive Officer, Director
- Matt KingDirector
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$9.9MraisedApr 2015 · 21 investors · OtherRule 506(b)
▶$9.9MraisedApr 2015 · 21 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ansbert GadickeDirector
- Matt KingDirector
- Joe SchmidtExecutive Officer
- Brad GeesamanDirector
- Robert KniejskiDirector
- Todd FoleyDirector
- Morana Jovan-EmbiricosDirector
- Philip RS Waugh, Jr.Director
- Douglas E. Pierce, Jr.Executive Officer, Director, Promoter
- Edward S. SeguineExecutive Officer, Director, Promoter
- Offering amount
- $9.9M
- Amount sold
- $9.9M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Clinical ink went on to found or lead other companies.
Related companies · 6
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Signant HealthSignant Health provides software platforms and clinical trial solutions for life sciences companies to manage patient-reported outcomes, evidence generation, and digital endpoints in drug development programs across multiple therapeutic areas.
MedableMedable provides a cloud-based platform for clinical research that uses AI and digital tools to accelerate the development of therapies by improving the quality, reach, and efficiency of clinical trials. The platform serves pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites.
CastorCastor developed decision-support software that analyzed CAD files to help manufacturers decide between additive manufacturing and traditional production, offering cost and lead-time comparisons.
MedidataMedidata is a clinical trial software platform that serves pharmaceutical, biotech, and healthcare organizations conducting clinical research. It provides end-to-end trial management, patient data analytics, and regulatory compliance solutions across thousands of trials and millions of patients globally.
PowerPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Companies working in the same space as Clinical ink.
In the news
Frequently asked questions
- What does Clinical ink do?
- Clinicalink offers a digital tool designed to improve drug adherence and measure the functional quality of weight loss. The product operates in the digital health space with clinical expertise spanning cardiology, rare disease, and oncology.
- Who founded Clinical ink?
- Clinical ink was founded by Douglas E. Pierce, Jr. in 2013.
- Who are Clinical ink's investors?
- Clinical ink's investors include FCA Venture Partners, McKesson Ventures, MPM BioImpact.
- How much funding has Clinical ink raised?
- Clinical ink has disclosed $16.9M raised across 3 rounds.
- Where is Clinical ink headquartered?
- Clinical ink is headquartered in Winston-Salem, US.